Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > beenthere and prophetoffacts
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(559)
•••
Comment by chrispion Dec 05, 2021 4:40pm
150 Views
Post# 34200410

RE:RE:RE:RE:RE:beenthere and prophetoffacts

RE:RE:RE:RE:RE:beenthere and prophetoffacts
Maybe it's just me but when I lose a large portion of an investment (which I have here)
I tend to leave it in place  with the outside hope (chance) that it might actually amount to something someday!

Then you are certifiably insane because in a previous post you said there is no hope for this loser company (I'm paraphrasing) and why would anyone invest. So, either you have memory problems (and don't know what you previously said), are a liar (and are talking the opposite of your book?), or just insane because why would you not sell your shares now and maximize the value IF you believe the shares will only go down in value (which can be assumed as your thinking based on your previous posts).

So beenthere, I'm done with you ... and no need to post the score between you and I as the game was won long ago by yours truly :)
It's been fine taunting you but I hope readers of this forum realize the lunacy in your posts and judge accordingly.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities